SCHEMBL8434091

SCHEMBL8434091

CCCCCCCCOc1ccc(CCC(=O)N[C@H]2[C@H](OCc3ccccc3)O[C@@H]3COC(C)(C)O[C@H]3[C@@H]2O)cc1OCCCCCCCC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CNR2 P34972 4/20 0.36
▸ MCHR1 Q99705 3/20 0.36
▸ CNR1 P21554 3/20 0.36
▸ SSTR3 P32745 5/20 0.35
▸ SSTR5 P35346 5/20 0.35
▸ SSTR2 P30874 3/20 0.35
▸ APP P05067 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ PTGES O14684 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ MTNR1A P48039 1/20 0.33
▸ MTNR1B P49286 1/20 0.33
▸ SSTR1 P30872 1/20 0.33
▸ SSTR4 P31391 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8431463 0.89 CNR2 (0.39) L3MBTL1CNR2HDAC1HDAC2
SCHEMBL8431552 0.88 L3MBTL1 (0.42) L3MBTL1MCHR1SSTR3SSTR5SSTR2
SCHEMBL10417607 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL6797796 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL10824776 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL6807464 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL6807462 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL6797801 0.80 L3MBTL1 (0.40) L3MBTL1MCHR1
SCHEMBL8435107 0.80 TLR4 (0.36) CNR2CNR1HDAC1HDAC2
SCHEMBL8435577 0.80 L3MBTL1 (0.39) L3MBTL1CNR2CNR1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36385-E TREATMENT OF TUMORS, ENHANCING IMMUNITY ONO PHARMACEUTICAL CO., LTD. (JP) 1999-11-09 — — US disclosed
EP-0288888-B1 Novel glucopyranose derivatives ONO PHARMACEUTICAL CO (JP) 1993-12-08 — — EP disclosed
US-4925929-A ANTITUMOR AGENTS ONO PHARMACEUTICAL CO. LTD. (JP) 1990-05-15 — — US disclosed
EP-0288888-A2 Novel glucopyranose derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1988-11-02 — — EP disclosed
Send feedback